Agile Therapeutics Inc (OTCPK:AGRX)
$ 1.51 0 (0%) Market Cap: 10.43 Mil Enterprise Value: 7.87 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 19/100

Q1 2021 Agile Therapeutics Inc Earnings Call Transcript

May 04, 2021 / 08:30PM GMT
Release Date Price: $3430 (-3.65%)
Operator

Good afternoon, and welcome to the Agile Therapeutics First Quarter 2021 Financial Results Conference Call. Please note today's event is being recorded.

I would now like to turn the conference over to Matt Riley, Head of Investor Relations.

Matthew Riley
Agile Therapeutics, Inc. - Head of IR & Corporate Communications

Hello, everyone, and welcome to today's conference call to discuss our first quarter 2021 financial results and corporate update. Before we start, let me remind you that today's call will include forward-looking statements based on current expectations, including statements concerning our financial outlook for the future, management's expectations for our future financial and operational performance, our business strategy, our assessment of the combined hormonal contraceptive market, and the potential market share for Twirla among other statements regarding our plans, prospects and expectations.

Such statements represent our judgment as of today, are not promises or guarantees and may involve risks and uncertainties that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot